Cytosorbents
CTSO
$0.82
Share price
1.24%
Change (1 day)
-66.71%
Change (1 year)
Categories
Cytosorbents (CTSO) - Total assets
Total assets on the balance sheet as of December 2023 : $53.26 M
According to Cytosorbents's latest financial reports the company's total assets are $53.26 M. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Cytosorbents - Total assets on balance sheet (from 2005 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $63.23 M | -29.37% |
| 2021-12-31 | $89.51 M | -0.48% |
| 2020-12-31 | $89.95 M | 228.5% |
| 2019-12-31 | $27.38 M | -19.93% |
| 2018-12-31 | $34.19 M | 41.88% |
| 2017-12-31 | $24.1 M | 148.65% |
| 2016-12-31 | $9.69 M | -13.87% |
| 2015-12-31 | $11.25 M | 32.89% |
| 2014-12-31 | $8.46 M | 109.32% |
| 2013-12-31 | $4.04 M | 21.15% |
| 2012-12-31 | $3.33 M | 57.33% |
| 2011-12-31 | $2.12 M | 17.14% |
| 2010-12-31 | $1.81 M | -19.06% |
| 2009-12-31 | $2.23 M | -33.91% |
| 2008-12-31 | $3.38 M | 322.04% |
| 2007-12-31 | $0.8 M | -76.7% |
| 2006-12-31 | $3.44 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Boston Scientific BSX | $35.13 B | 65,869.97% | 🇺🇸 USA |
 Hologic HOLX | $8.46 B | 15,802.00% | 🇺🇸 USA |
 Meridian Bioscience VIVO | $0.46 B | 769.49% | 🇺🇸 USA |